April 27, 2021

Case Study: Theradaptive and Regenerative Medicine


How working with Geneva set the foundation for technology transfer and clinical success.


Geneva has worked with Theradaptive, Inc., a privately-held biotechnology company focused on regenerative medicine technology, on getting their therapeutic platform into the clinic since 2017. The company’s founder is a 20-year Army veteran and MIT alumnus retired LTC Luis Alvarez, PhD. LTC Alvarez developed the platform technology during active duty in the Army.

In this Case Study, you will find:

  • The role of tech transfer in the military
  • Theradaptive’s impact on healthcare
  • Geneva’s tech transfer capabilities
  • Map of military treatment facilities Geneva is working with to advance regenerative medicine

Geneva is proud to have over 25 years of experience in delivering full-spectrum scientific, technical, and program management expertise in the areas of federal contracts, federal grants, and industry-sponsored clinical trials.